News - 4 Oct 2008
Dicerna Pharmaceuticals, Inc. a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), announced today a paper appearing in the...
News - 28 Aug 2008
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), today announced that LGC, an international leader in laboratory services and measurement standards, has purchased a...
Article - 23 Aug 2006
The vision for nano-assisted regenerative medicine is the development of cost-effective disease-modifying therapies that will allow for in-situ tissue regeneration.
Article - 28 Jun 2005
Research in the field of nanobiotechnology could help to improve the ways in which cancer is detected and treated. Medical imaging, labeling methods, quantum dots, nanosensors, lab on a chip devices,...
News - 31 Mar 2014
Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define...
News - 24 Oct 2011
Research and Markets has added a new report titled "Nanobiotechnology Applications, Markets and Companies" from Jain PharmaBiotech, to its biotech market research portfolio. The applications...
News - 10 Nov 2010
A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU),...
Article - 23 Apr 2004
Arrowhead Research Corporation, an emerging company in the field of nanotechnology, has agreed to take a majority position in Insert Therapeutics, a company focused on designing, developing and...
News - 20 Nov 2018
The life of Michel Meunier, an engineer and professor at Polytechnique Montréal, changed significantly in January 2009. Similar to others, he had noticed that the exceptionally short pulse of a...
News - 2 Jun 2015
Research and Markets has announced the addition of Jain PharmaBiotech's new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.